1OAQ | H:1-120; L:1-110 | FREE CONFORMATION AB1 OF THE IGE SPE-7 |
1OAR | H:1-122; O:3-109; M:3-109; L:2-109; N:2-109; J:1-122; I:14-116; K:14-116 | FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED |
1OAU | H:1-122; L:2-109; N:2-109; O:6-109; M:6-109; J:1-122 | FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN) |
1OAX | H:1-122; J:1-122; O:2-109; L:2-109; M:2-109; N:2-109 | FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE |
1OAY | H:2-122; J:2-122; N:2-109; L:2-109; O:2-109; M:2-104 | ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY |
1OAZ | H:1-122; L:2-109; N:2-109; J:1-122 | IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN |
1OCW | H:1-120; L:1-110 | FREE CONFORMATION AB2 OF THE IGE SPE-7 |